Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity. |
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
RfSyfhW4ucvpeqUV
Listen
